Summary of mergers and acquisitions of domestic life and health industry enterprises in the first half of 2017

Source: Sina pharmaceutical 2017-08-04 In 2017, capital continued to strengthen the structure and influence of life and health industry, and the industry layout and integration speed of leading enterprises accelerated According to hsmap statistics, in the first half of 2017, there were 29 M & A events in the domestic life and health industry, involving a total amount of 31.1 billion yuan, including 10 in the pharmaceutical field, 7 in the device field, 10 in the medical service field, and 2 in the IVD field Non public medical and cro became the focus of industry integration in the first half of 2017, with 6 M & A events involving about 4.1 billion yuan In terms of M & A enterprises, aer ophthalmology and Sanyou group were more active in completing two overseas M & A events in the first half of the year, of which Sanyou group spent about 10.2 billion yuan on two acquisitions In the first half of 2017, the largest M & A of China's life and health industry was cny5.7 billion acquisition of 100% equity of dentreon, the US biomedical company Dentreon is the world's first owner of Provenge for prostate cancer cell immunotherapy On April 29, 2010, the U.S FDA officially approved the use of Provenge from dendreon company to treat asymptomatic or slightly symptomatic metastatic castration resistance (hormone refractory) prostate cancer It became the first prostate cancer auto immunotherapy approved by the U.S FDA and the only cell immunotherapy for advanced prostate cancer at present List of domestic life and health industry M & A in the first half of 2017 1 There are 9 drug M & A, involving about RMB 15.2 billion The business of the acquired party mainly includes: Traditional Chinese medicine, API, plasma products, injection, etc the acquired party includes: Honghe Pharmaceutical: the business scope of Honghe Pharmaceutical (China) is large volume injection production and drug research, technology transfer and technical services; currently, the drug production approval documents held include glycyrrhizic acid monoammonium cysteine sodium chloride injection and xingxiong sodium chloride injection Bo Hao Bio: Bo Hao bio is a major manufacturer of marigold extract in China, specializing in the R & D, production and sales of lutein and other natural plant extracts Jiuhua pharmaceutical: Jiangxi Jiuhua pharmaceutical is a national high-tech enterprise mainly engaged in the production of Chinese patent medicine The main products of the company are: Jiuhua hemorrhoid suppository, Cordyceps Chuanbei ointment, Yaotong pill, compound infantile antipyretic suppository, Fengshigutong liquor, etc Kangli pharmaceutical: the main varieties of Hainan Kangli include piperacillin sulbactam, alanyl glutamine, etc.; more than 50 products are in production and sale, mainly including freeze-dried powder injection and sterile powder injection, covering the main fields of antibiotics, nutrition medicine, cardio cerebrovascular medicine, etc Newchem: mainly engaged in the research and development, production and sales of bulk drugs, mainly steroids and hormone drugs, as well as the application research in agriculture, food industry, environmental protection industry, beauty industry and physiotherapy industry Effechem: mainly engaged in various sales activities in the pharmaceutical industry Saisheng pharmaceutical products mainly cover the fields of tumor, infectious disease and cardiovascular disease, and the exclusive product Rita Xian (thymus method new) was launched in 1996 Founded in July 2011, Jilin Fukang Pharmaceutical Co., Ltd has two exclusive products, Yixuesheng capsule and Jinfukang oral liquid Wuhan Zhongyuan Ruide: develop, produce and sell plasma products for China's domestic market, including albumin, intravenous human immunoglobulin and some special immunoglobulin products Jiangxi Diwei Pharmaceutical Co., Ltd.: it is a pharmaceutical company mainly engaged in pediatrics and cold medicine Dendreon is the owner of Provenge, the world's first prostate cancer cell immunotherapy 2 There are 7 acquisitions of medical devices, involving about 4.8 billion yuan The business of the acquired party mainly includes consumables, gastroenteroscope, minimally invasive equipment, etc the acquired party includes babybloom: design and manufacture of baby incubator, which has won many awards and entered many large hospitals The new design of nursing premature infants has attracted the attention of the international market, and it is very convenient for both mothers and infants CDI: founded in 2007, it has developed into a leading brand of denture factory in Sweden within 10 years, and set the industry standard in denture field Anrui Medical Equipment Co., Ltd.: established in 2006, the company is committed to the research and development, production and sales of gastrointestinal minimally invasive surgical instruments Its official website shows that Anrui medical products cover gastrointestinal endoscopy series, ERCP, choledochoscopy series, stent series, early cancer treatment series, etc MedTech medical: a professional company specializing in the development and manufacture of radio-frequency minimally invasive treatment equipment The company's main products are radio-frequency therapeutic apparatus and its supporting accessories - radiofrequency ablation electrode needle, which are used for ablation treatment of various tumors, including liver, lung, thyroid, breast and other organs and tissues, and have obtained CFDA certification Metrix: R & D, production and sales of emergency medical products, including primedic primecon automatic external defibrillator (AED) and professional defibrillator for emergency centers and hospital clinics It is reported that Tobias mohry, the former general manager of matrax company, will be retained after the acquisition Breas: the main business is to produce home care ventilation and sleep apnea equipment, the products are mainly sold to Europe and the United States Fosun plans to introduce Breas related products into the Chinese market through the acquisition Ansell: a leader in the global gender health business market Its condom business ranks the second in the global market, with a variety of well-known brands including jesbond, zero sense MANIX and blowtex 3 There are two acquisitions of diagnostic reagents, involving about 1.8 billion yuan The business of the acquired party mainly includes POCT and immunodiagnosis The acquired party includes Enji and mainly engaged in the production and sales of in vitro diagnostic reagents Lepu medical is mainly engaged in cardiac stent business, and in recent years began to lay out the field of in vitro diagnosis (IVD) As one of the main POCT product suppliers in the domestic market, Rayleigh biology provides POCT products mainly for cardiac markers, infection and inflammation detection for various medical laboratories In the field of POCT detection, it has high-quality solutions and mature product platforms, as well as a good market channel foundation 4 There are 10 M & A of medical services, involving about 9.2 billion yuan The business of the acquired party mainly includes: non-public medical, CRO, drug sales, etc the acquired party includes: gift and medicine: the predecessor of the company, Beida Pharmaceutical Sales Co., Ltd., a subsidiary of Beida pharmaceutical, a listed company Runxiang Pharmaceutical Co., Ltd is a large-scale pharmaceutical logistics and distribution business company in Hebei Province, with the core of sales, agency, promotion, storage and transportation, modern pharmaceutical logistics and distribution system and information management mode Affinity source is a professional service company which is engaged in the operation and management of the membership pension community and provides pension service It was founded in 2005 Affinity source mainly runs four product lines, covering elderly care community, leisure elderly care, medical care, elderly care consultation and entrusted operation Fandi biology was founded on June 1, 2011, mainly engaged in non-invasive prenatal gene testing (NIPT), genetic analysis of folate metabolism disorders, neonatal genetic and metabolic disease screening and other testing services related to eugenics and eugenics; individual drug-based testing services such as tumor targeting drugs, tumor chemotherapy drugs, etc., with third-party independent medical testing qualification Xiongchu Hospital of traditional Chinese and Western medicine is a unique hospital integrating traditional Chinese and Western medicine with medical treatment, teaching, scientific research, prevention, health care and health preservation It has Hubei station of thyroid patients' liaison office and Hubei station of hemangioma patients' friendship office Wang vision is a world-renowned eye center with cutting-edge refractive surgery technology and comprehensive corneal imaging technology CL í Nica Baviera, S.A is the largest chain of ophthalmic medical listed institutions in Europe, with decades of development history and nearly 300 ophthalmologists and optometrists Smart Chemical Research Co., Ltd is a leading research outsourcing service organization (CRO) in the world It provides pharmaceutical R & D services and helps pharmaceutical and biotechnology companies develop new drugs more effectively in drug research and development Kananji pharmaceutical is located in Zhangjiang High Tech Park It is a high-tech start-up company for overseas students who use Vic business model and cro R & D outsourcing service to research and develop new drugs At present, it is mainly engaged in the research and development of targeted new drugs CM082 Headquartered in Shanghai, Huiyuan biology is the leading preclinical R & D service platform in the industry, which mainly provides a series of preclinical drug development services such as drug target validation, in vitro efficacy evaluation based on microplate, active compound identification, lead compound discovery, in vivo pharmacology research, etc.